biote Corp. (BTMD) stock
BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$1.06+0.03 (+3.40%)
Close on Nov 13, 2026Market cap $38.26MP/E –Yield –
biote ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
biote's ebitda for the twelve months ending Sep 30, 2026 was $12.90M, down 63.5% year over year. For fiscal 2025 it was $39.22M, up 11.5% from the year before. The highest annual figure on record is $39.22M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.22M | +11.5% |
| FY2024 | Dec 31, 2024 | $35.19M | +11.2% |
| FY2023 | Dec 31, 2023 | $31.65M | – |
| FY2022 | Dec 31, 2022 | -$58.52M | -262.7% |
| FY2021 | Dec 31, 2021 | $35.96M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.52M | -61.9% |
| Q2 FY2026 | Jun 30, 2026 | -$2.55M | -121.8% |
| Q1 FY2026 | Mar 31, 2026 | $4.15M | -60.7% |
| Q4 FY2025 | Dec 31, 2025 | $7.78M | +99.2% |
| Q3 FY2025 | Sep 30, 2025 | $9.22M | -29.1% |
| Q2 FY2025 | Jun 30, 2025 | $11.68M | +64.2% |
| Q1 FY2025 | Mar 31, 2025 | $10.55M | -5.6% |
| Q4 FY2024 | Dec 31, 2024 | $3.91M | -44.4% |
| Q3 FY2024 | Sep 30, 2024 | $12.99M | +62.1% |
| Q2 FY2024 | Jun 30, 2024 | $7.11M | -13.3% |
| Q1 FY2024 | Mar 31, 2024 | $11.18M | +32.8% |
| Q4 FY2023 | Dec 31, 2023 | $7.02M | -10.7% |
| Q3 FY2023 | Sep 30, 2023 | $8.02M | -4.5% |
| Q2 FY2023 | Jun 30, 2023 | $8.20M | – |
| Q1 FY2023 | Mar 31, 2023 | $8.42M | -18.0% |
| Q4 FY2022 | Dec 31, 2022 | $7.86M | +24.0% |
| Q3 FY2022 | Sep 30, 2022 | $8.40M | -9.9% |
| Q2 FY2022 | Jun 30, 2022 | -$85.04M | – |
| Q1 FY2022 | Mar 31, 2022 | $10.27M | – |
| Q4 FY2021 | Dec 31, 2021 | $6.34M | – |
| Q3 FY2021 | Sep 30, 2021 | $9.32M | – |
See a number that looks wrong?